26
Feb

Pushing through on a plan to get out of the early-stage anti-infectives R&D space, AstraZeneca is spinning out its Waltham, MA-based company into an independent biotech, a move that will have an impact on the 95 staffers remaining in the swiftly dwindling operation.

…read more

Source: Exclusive: AstraZeneca spinning out its anti-infectives R&D unit in Waltham

    

0 No comments